1,6-diaminohexane has been researched along with Gangliosidosis, GM1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fröhlich, RF; Furneaux, RH; Mahuran, DJ; Saf, R; Stütz, AE; Tropak, MB; Wicki, J; Withers, SG; Wrodnigg, TM | 1 |
1 other study(ies) available for 1,6-diaminohexane and Gangliosidosis, GM1
Article | Year |
---|---|
1-Deoxy-D-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines.
Topics: 1-Deoxynojirimycin; Animals; Bacterial Proteins; beta-Galactosidase; Cats; Cell Line; Dansyl Compounds; Diamines; Enzyme Inhibitors; Fluorescent Dyes; Gangliosidosis, GM1; Humans; Imines; Kinetics; Lysosomes; Molecular Chaperones; Molecular Probes; Molecular Targeted Therapy; Phosphatidylcholines; Plant Proteins; Sugar Alcohols | 2011 |